Skip Main Navigation
Page Content

Save This Event

Event Saved

Boston's Life Science Disruptors


Thursday, September 28, 2017 from 6:00 PM to 7:45 PM (EDT)

Registration Information

Registration Type Sales End Price Fee Quantity
Super Saver Jun 8, 2017 $125.00 $3.49
Startup Special
For employees of startups less than 3 years old with 20 or fewer employees.
Sep 28, 2017 $110.00 $3.19
Student Registration
For full-time students only; limited number available. Valid student ID must be shown at registration desk.
Sep 28, 2017 $50.00 $1.99
Regular Registration Sep 28, 2017 $175.00 $4.49

Share Boston's Life Science Disruptors

Event Details

For the full list of speakers and event information, visit our event site.  

Disruption in biotech can come in different forms, from new technologies that can change the face of medicine, to ideas and initiatives that can challenge the status quo. Boston has both of these in spades, with ambitious biotech startups bent on transforming drug development and industry leaders unafraid to tackle the sector’s toughest issues. But which new companies are forging the most radical paths and are poised to become the biggest disruptors? What is their approach to building a great biotech company, and how are their founders working with leading venture capital investors to pull it off?

Join Xconomy for this annual evening event featuring candid stories from some of New England’s most radical company leaders, founders, and VC backers out to change the game in biotech.

2016 Speakers:

  • Vicki L. Sato, Professor of Management Practice, Harvard Business School
  • Terry McGuire, Founding Partner, Polaris Partners
  • Scott Manalis, Professor of Biological and Mechanical engineering, MIT
  • Nessan Bermingham,Co-founder, CEO, & President, Intellia Therapeutics
  • Jean-Francois Formela, Partner, Atlas Ventures
  • Geraldine Hamilton, President & Chief Scientific Officer, Emulate
  • Donald Ingber, Founding Director, Wyss Institute for Biologically Inspired Engineering at Harvard
  • Anne E. Deconinck, Executive Director, Koch Institute for Integrative Cancer Research at MIT


Registration & Networking: 5:00 - 6:00 pm
Program: 6:00 pm - 7:45 pm
Networking reception: 7:45 - 8:45 pm

Tickets are transferable but not refundable.
To inquire about press registration, contact

*Speakers and program schedule are subject to change. 





  Bayer           GE

Shire          WuXi AppTec


 Alexandria Real Estate Equities


Biocrossroads • GE • Latham & Watkins
TEVA Pharmaceuticals • Texas Medical Center • UT Health Science Center

ARCH Venture Partners • Avalon Ventures • Flagship Pioneering•  G20 • General Catalyst Partners
North Bridge Venture Partners • Polaris Partners • RA Capital • Santé Ventures • SR One • Third Rock Ventures

Acorda Therapeutics • Arrowhead Pharmaceuticals 
Bayer • Foundation Medicine • Genocea Biosciences • Health Advances • Shire •Synlogic Therapeutics

Have questions about Boston's Life Science Disruptors? Contact Xconomy

Save This Event

Event Saved

When & Where

610 Main St
Cambridge, MA 02139

Thursday, September 28, 2017 from 6:00 PM to 7:45 PM (EDT)

  Add to my calendar



Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit/Ann Arbor, Indiana, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at

Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.